For many FemTech founders, convincing investors of the potential of their startup (especially beyond reproductive health) can be a struggle. Why so many investors overlook this sector? Learn ways to break down those barriers and secure the backing you need to innovate.

In this episode you’ll hear about:

👉🏻 Overcoming Investment Barriers for FemTech Startups

👉🏻 Strategies for Effective Pitching and Investor Connection

👉🏻 Trends Shaping FemTech and Women’s Health

👉🏻 Challenges with Regulatory Processes in HealthTech

👉🏻 Building Inclusive Health Solutions for Diverse Populations

Our guest is Mitzi Krockover, M.D., Founder and CEO of Woman Centered, LLC; host and producer of the Beyond the Paper Gown podcast

Mitzi Krockover, M.D., is the Founder and CEO of Woman Centered, LLC and the host and producer of the Beyond the Paper Gown podcast, which inspires and informs women to achieve their optimal health. Additionally, she is a Managing Director at Golden Seeds, an angel investment organization that focuses on funding early-stage companies led by women; she co-leads the Health Sector Committee. Dr. Krockover previously served as the founding Medical Director of the Iris Cantor-UCLA Women’s Health Center and as Vice President of Women’s Health at Humana Inc. Dr. Krockover also serves on the boards of the Institute for Mental Health Research, the Black Women’s Health Imperative and Springboard’s Women’s Health Innovation Council. A Board-Certified internist, she received her undergraduate degree at Washington University, her MD at the University of Texas at San Antonio and completed her internal medicine residency at Northwestern McGaw Medical Center.

You can find our guest here:

👉🏻 https://www.linkedin.com/in/mitzikrockover/

👉🏻 https://www.beyondthepapergown.com/

Follow and find more inspiration:

👉🏻 https://www.themomentum.ai/insights

👉🏻 https://www.linkedin.com/company/the-momentum-ai/

What happens when your tech solution needs more than just a software update? From an ambitious API to a comprehensive care system — listen to the story of how one healthtech company pivoted to meet the real needs of patients. Discover how healthtech can break through regulatory barriers, gain patient trust, and offer personalized care without losing the human touch.

In this episode you’ll hear about:

👉🏻 Challenges of scaling healthtech solutions

👉🏻 The disparity between the standard of maternal care in the U.S. and what could be achieved with better tech solutions

👉🏻 Navigating complex healthcare regulations

👉🏻 The journey from building a tech-heavy API solution to creating a more comprehensive system of care

👉🏻 Addressing concerns around data privacy

Our guest is Senan Ebrahim, the Founder and CEO of Delfina

Senan Ebrahim, the Founder and CEO of Delfina, is a physician-scientist and entrepreneur with an MD and Ph.D. in Computational Neuroscience from Harvard, dedicated to using technology to improve global health. He has worked for over a decade at the intersection of AI and healthcare and previously founded Hikma Health, a tech nonprofit creating digital health solutions for refugees, migrants, and vulnerable populations. Senan co-founded Delfina in 2021 to bring lifesaving technologies to prenatal care after experiencing the challenges faced by parents and their providers alike.

You can find our guest here:

👉🏻 https://www.linkedin.com/in/senane/

👉🏻 https://www.delfina.com/

Applover⁠ is an ISO 13485-certified Full-Stack Digital Agency from Wrocław, Poland. Founded in 2016, a team of nearly 160 experts has developed over 200 projects. Applover was recognized by the Financial Times in the 'FT 1000' ranking in 2023 and by Deloitte as a Rising Star (Fast 50 Tech) in the CEE region in 2019, and in 2020 and 2021, in the main category of the FAST 50 ranking.

Follow and find more inspiration:

👉🏻 https://applover.com/blog/

👉🏻 https://www.linkedin.com/company/applover-software-house/

Fertility and cryogenics are rich grounds for innovation, but it’s not enough to have a good idea. What separates the successful startups from those that fizzle out? In cryogenic storage, one slip can mean the loss of invaluable reproductive material. How do new technologies protect against failures, and what steps are being taken to make storage safer than ever before?

In this episode you’ll hear about:

👉🏻 Advancements in Cryogenics and Fertility Treatments

👉🏻 Risk Mitigation in Cryogenic

👉🏻 Opportunities for Healthtech Startups in Fertility and Cryogenics

Our guest is Christine Allen, Director of IVF laboratory operations, Scientific Advisor at CryoFuture

Dr. Christine Allen is a certified embryologist and andrologist who has travelled the world developing and teaching leading edge vitrification and lab automation technologies, building IVF clinics and implementing new technologies as AI research, state-of-art egg banking, non-invasive PGTA and data analytics for success improvement. Christine’s research in cryopreservation, vitrification techniques and fertilization has been published in several leading industry journals and she has presented her findings at ASRM, ESHRE and American Board of Bioanalysts (ABB) among others. She has a proven track record of the direct implementation of embroyology lab management, quality control procedures, andrology testing, outside clinician consulting and is an expert in US Food and Drug Administration (FDA), Clinical Laboratory Improvement Amendments (CLIA), American Association of Bioanalysts AAB and ASRM laboratory standards. She is also fluent in English, Portuguese, French and Italian, and proficient in Dutch and Spanish, directing labs around the world in their native languages. As per her investor endeavors, Dr. Allen focus on supporting new technologies startups related to scientific breakthroughs in IVF that could lead to better safety measures and higher quality of laboratory operations.

You can find our guest here:

👉🏻 https://www.linkedin.com/in/christine-a-2a9b66a/

👉🏻 https://www.fertilityconsultancy.com/

👉🏻 https://eliteivfteam.com/

Applover⁠ is an ISO 13485-certified Full-Stack Digital Agency from Wrocław, Poland. Founded in 2016, a team of nearly 160 experts has developed over 200 projects. Applover was recognized by the Financial Times in the 'FT 1000' ranking in 2023 and by Deloitte as a Rising Star (Fast 50 Tech) in the CEE region in 2019, and in 2020 and 2021, in the main category of the FAST 50 ranking.

Follow and find more inspiration:

👉🏻 https://applover.com/blog/

👉🏻 https://www.linkedin.com/company/applover-software-house/

What are some of the most overlooked inefficiencies in healthcare supply chains and administration that lead to unnecessary expenses and wasted resources? Find out practical solutions to eliminate these inefficiencies and how optimizing operations can have a profound impact - from streamlining operations, through saving money, to improving patient care.

In this episode you’ll hear about:

👉🏻 Healthcare supply chain inefficiencies

👉🏻 Electronic Health Records (EHR) and Predictive Analytics:

👉🏻 Ethical considerations in healthtech

👉🏻 Global healthcare challenges and opportunities

Our guest is Dr. Costas Fantis, Founder and the CEO of Encode Health

Dr. Costas Fantis is an accomplished and innovative leader in the field of digital health and neurosurgery, currently the founder and the CEO of Encode Health. His medical career is distinguished by a profound commitment to merging cutting-edge technology with clinical expertise to revolutionize healthcare delivery.

A medically trained doctor with a specialist interest in neurosurgery, Dr. Fantis completed his degree in Neurosurgery with outstanding achievement and has conducted pivotal research on the applications of artificial intelligence (AI) in neurosurgery at Buckingham University (UK). His work in this area, particularly on molecular diagnostics and AI in gliomas, has garnered recognition and led to presentations at esteemed conferences such as the Society of British Neurosurgeons.

Prior to his role at Encode Health, Dr. Fantis was the lead surgical officer at Touch Surgery in London. There, he pioneered the innovative use of app-based platforms to teach surgery. He collaborated with world-renowned surgeons and medical device corporations, distilling complex surgical procedures into accessible, animated guides that have trained surgeons globally. This role underscored his ability to translate high-level surgical techniques into practical, digital learning tools, enhancing surgical education worldwide.

In addition to his surgical and digital health expertise, Dr. Fantis has also contributed significantly to gynecology through his work at Dr. Morton’s, where he facilitated remote consultations in both primary and secondary care. His entrepreneurial spirit was evident early in his career when he founded and operated the largest medical summer school, providing crucial guidance to aspiring medical students on entering their chosen specialties.

Dr. Fantis's diverse background also includes military service as a tank driver, showcasing his adaptability and resilience. His multifaceted experiences have fueled his passion for leveraging technology, particularly AI, to bridge the gap between medical supply and clinical demand, ultimately transforming healthcare delivery.

Dr. Fantis continues to push the boundaries of medical innovation, driven by a vision to enhance patient outcomes and streamline healthcare processes through digital solutions and AI. His dynamic career and unwavering dedication make him a trailblazer in the integration of technology in medicine.

You can find our guest here:

👉🏻 https://www.linkedin.com/in/dr-cos-fantis-02b7b960/

👉🏻 cosfantis@encodehealth.com

Applover⁠ is an ISO 13485-certified Full-Stack Digital Agency from Wrocław, Poland. Founded in 2016, a team of nearly 160 experts has developed over 200 projects. Applover was recognized by the Financial Times in the 'FT 1000' ranking in 2023 and by Deloitte as a Rising Star (Fast 50 Tech) in the CEE region in 2019, and in 2020 and 2021, in the main category of the FAST 50 ranking.

Follow and find more inspiration:

👉🏻 https://applover.com/blog/

👉🏻 https://www.linkedin.com/company/applover-software-house/

Healthcare systems face obstacles in adopting virtual care solutions like EICU. From financial constraints to staff resistance, uncover the main barriers to widespread implementation. Less than half of health systems have adopted these technologies so what can be done to overcome these challenges? What key factors are preventing broader acceptance and integration?

In this episode you’ll hear about:

👉🏻 Evolution and impact of digital health technology on patient care.

👉🏻 Concept and implementation of EICU (Electronic Intensive Care Unit).

👉🏻 Challenges in deploying virtual care solutions, such as costs and staff resistance.

👉🏻 Strategies for engaging healthcare professionals and patients with new technology.

👉🏻 Role of virtual nursing in patient care and staff sustainability.

Our guest is Sarah J. Bell, MSN, MHA, RN, former Vice President of Product and Clinical Implementation, Biofourmis.

Sarah is an accomplished healthcare professional with a robust background in nursing and administration. Holding a Bachelor of Science in Nursing from Coe College, Cedar Rapids IA, and dual master’s degrees in nursing and health administration from the University of Phoenix, Sarah’s educational foundation is complemented by over two decades of practical experience.

Her nursing journey began in 2005 at the prestigious Mayo Clinic, where she honed her skills in various clinical settings, including the Medical Cardiac Progressive Care Unit and Medical ICU. Demonstrating exceptional leadership, Sarah spearheaded Mayo Clinic’s pioneering eICU initiative in 2013, serving as Nurse Manager until 2020. During this time, she facilitated the establishment of Mayo Clinic’s first Virtual RN program, benefiting hundreds of patients across the organization.

Recognized for her contributions, Sarah earned certification as a Silver Mayo Quality Fellow and held the academic rank of Instructor of Nursing in the Mayo Clinic College of Medicine and Science.

In 2023, driven by her passion for digital health, Sarah transitioned to the vendor side, joining Biofourmis as Vice President of Customer Success and Clinical Implementation. She served as Vice President of Product and Clinical Implementation, she lead a dynamic team of engineering professionals, overseeing the development and support of a cutting-edge platform aimed at optimizing transitions of care. With her wealth of experience and dedication to advancing healthcare technology, Sarah continues to make significant strides in reshaping the digital health landscape.

You can find our guest here:

👉🏻 https://www.linkedin.com/in/sarah-bell-rn-msn-mha-8a87459a/

Applover⁠ is an ISO 13485-certified Full-Stack Digital Agency from Wrocław, Poland. Founded in 2016, a team of nearly 160 experts has developed over 200 projects. Applover was recognized by the Financial Times in the 'FT 1000' ranking in 2023 and by Deloitte as a Rising Star (Fast 50 Tech) in the CEE region in 2019, and in 2020 and 2021, in the main category of the FAST 50 ranking.

Follow and find more inspiration:

👉🏻 https://applover.com/blog/

👉🏻 https://www.linkedin.com/company/applover-software-house/

Offering comprehensive fertility services across multiple countries is no small feat. Discover the operational complexities and technological hurdles involved, from understanding diverse healthcare regulations to ensuring the privacy of sensitive data. What frameworks are essential for scaling such services, and how do you maintain quality and compliance in a fragmented market?

In this episode you’ll hear about:

👉🏻 Inclusivity in Fertility and Family Planning

👉🏻 Business Models and Market Strategy

👉🏻 How to offer fertility services across various countries

👉🏻 Challenges in raising funds for FemTech startups

👉🏻 Jenny’s experience as both a founder and an angel investor

Our guest is Jenny Saft, CEO & co-founder of Apryl.

Jenny Saft is the CEO and co-founder of Apryl. Prior to starting Apryl, Jenny worked in project management and Business Development at several big companies, including Fyber in San Francisco and Dutch fintech Adyen. She was inspired to start Apryl following her own experience of freezing her eggs.

You can find our guest here:

👉🏻 https://www.linkedin.com/in/jennysaft/

👉🏻 https://apryl.co/

Applover⁠ is an ISO 13485-certified Full-Stack Digital Agency from Wrocław, Poland. Founded in 2016, a team of nearly 160 experts has developed over 200 projects. Applover was recognized by the Financial Times in the 'FT 1000' ranking in 2023 and by Deloitte as a Rising Star (Fast 50 Tech) in the CEE region in 2019, and in 2020 and 2021, in the main category of the FAST 50 ranking.

Follow and find more inspiration:

👉🏻 https://applover.com/blog/

👉🏻 https://www.linkedin.com/company/applover-software-house/

Breaking into FemTech is no small feat, especially when faced with funding hurdles and regulatory challenges. Kristina Cahojova's journey from Big Tech to launching kegg highlights the importance of passion and perseverance. Discover how cultural differences between US and European startups shaped her strategy and why aligning business with personal passion is crucial. What lessons can aspiring founders take from her inspiring journey?

In this episode you’ll hear about:

👉🏻 Challenges in FemTech Innovation and Fundraising

👉🏻 Differences Between US and European Startup Ecosystems

👉🏻 Navigating Hardware and Regulatory Challenges

👉🏻 Scaling into Asian Markets

Our guest is Kristina Cahojova, Founder & CEO at kegg

Kristina Cahojova is a Founder & CEO at kegg. 10+ years of go-to-market and growth experience from Amazon, eBay, and startups. Previously led growth at AppyParking, which became the most downloaded parking app. Started kegg because of difficulties with her health and subsequently self-funded the company until 2019. Kristina holds 2 masters degrees from leading European schools in Business Administration and International Management.

You can find our guest here:

👉🏻 https://kegg.tech/

👉🏻 https://www.linkedin.com/in/kristinacahojova/

Applover⁠ is an ISO 13485-certified Full-Stack Digital Agency from Wrocław, Poland. Founded in 2016, a team of nearly 160 experts has developed over 200 projects. Applover was recognized by the Financial Times in the 'FT 1000' ranking in 2023 and by Deloitte as a Rising Star (Fast 50 Tech) in the CEE region in 2019, and in 2020 and 2021, in the main category of the FAST 50 ranking.

Follow and find more inspiration:

👉🏻 https://applover.com/blog/

👉🏻 https://www.linkedin.com/company/applover-software-house/

Women face unique challenges in HealthTech. What strategies are useful in overcoming them? Having women in leadership roles is crucial for addressing women's health issues and driving industry progress. Find out the secrets to succeeding in a field where women often have to work harder to be seen and heard.

In this episode you’ll hear about: 👉🏻 Advocacy for women in leadership 👉🏻 Advice for aspiring female entrepreneurs and leaders 👉🏻 The significance of networking in establishing collaborations 👉🏻 Measuring Impact of Health Initiatives

Our guest is Marissa Fayer, CEO & founder of non-profit HERhealthEQ, CEO of DeepLook Medical.

Marissa Fayer is a 20+ medtech executive, innovator, entrepreneur, investor, and philanthropist. She is the CEO and founder of non-profit HERhealthEQ, CEO of DeepLook Medical, Entrepreneur-in-Residence at Graybella Capital, and Co-Chair of the US AI for Good Innovation Factory. Her mission is to move innovation and the health of women forward throughout the world. Through her work with DeepLook Medical, Marissa has commercialized the FDA-cleared technology with 4 commercial sales and distribution partnerships, raised $2M in Seed capital, has increased publicity of the company by being featured in Forbes, FemTechInsider, and FemTechWorld, and has spoken at some of the largest healthcare conferences in the world. Though her work with HERhealthEQ, Marissa has led the organization to improve the health of 41,000 women in 9 different countries around the world. Her leadership has built the board, deployed 35+ pieces of equipment, won the PIR.Org Impact Health award in 2023, and led the fundraising efforts to support the treatment, detection, and/or prevention of breast cancer, cervical cancer, and maternal health for women globally. Marissa has previously served as an executive at Hologic, Olympus (formerly ACMI), Maquet-Getting (formerly Atrium Medical), Providien Medical, and Accumed Innovative Technologies. Her consulting clients include many of the Top 500 healthcare companies and innovative start-ups including Pfizer, Boehringer Ingelheim, Nuvasive, the National Institute of Health (NIH), Oerlikon Medical, Lonza Precision Medical, Emit Imaging, and others. Marissa sits on the board of medtech companies Welwaze Medical and DeepLook Medical both focused on improving the diagnosis of breast cancer; and an Advisor to Impact.51 which is an Israeli accelerator focused on women’s health. Marissa graduated from Boston University with a BS in Manufacturing Engineering, from University of Connecticut with an MBA, and from the IESE Business School in Barcelona of the Global Health Innovation Management program. Marissa is a TEDx Speaker (2019 at TEDxLugano), a UCSC Miller Center Social Entrepreneur Fellow, and has been listed as one of the Top 100 Women in Medtech, a 2024 MedTech Voice to Watch, a First in FemTech award winner in 2022, awarded the Africa Development Award, a Wonder Women in Medtech, and has delivered keynote discussions at some of the leading global healthcare conferences around the world.

Marissa is dedicated to innovative solutions for global women’s health throughout the world. Marissa lives in New York City and can be found at http://www.marissafayer.com

You can find our guest here: 👉🏻 http://www.marissafayer.com 👉🏻 https://www.linkedin.com/in/marissa-fayer/

Applover⁠ is an ISO 13485-certified Full-Stack Digital Agency from Wrocław, Poland. Founded in 2016, a team of nearly 160 experts has developed over 200 projects. Applover was recognized by the Financial Times in the 'FT 1000' ranking in 2023 and by Deloitte as a Rising Star (Fast 50 Tech) in the CEE region in 2019, and in 2020 and 2021, in the main category of the FAST 50 ranking.

Follow and find more inspiration: 👉🏻 https://applover.com/blog/ 👉🏻 https://www.linkedin.com/company/applover-software-house/